laitimes

Although the fund company continued to increase its holdings, the stock price of Tongce Medical still fell and fell. Therefore, the increase in fund holdings cannot be the only basis for judging the trend of stock prices. Copy homework, the key is to see

author:Lie win investment

Although the fund company continued to increase its holdings, the stock price of Tongce Medical still fell and fell.

Therefore, the increase in fund holdings cannot be the only basis for judging the trend of stock prices.

The key to copying homework is to look at the fundamentals of the company.

The core driving the rise in stock prices is the performance of enterprises, not the positions of external investors.

Fund Name Number of shares held (10,000 shares) Position trend

The China-Europe Healthcare Hybrid A 1571.13 continued to increase holdings

GF Healthcare stock A 400.00 continued to increase holdings

CEIBS Medical Innovation Stock A 389.58 continued to increase holdings

Huabao CSI Medical ETF 240.79 continued to increase holdings

Harvest Emerging Industries Stock 209.93 Continuous Reduction

NORD Value Advantage Blend 190.33 continuous overweight

Harvest and Hybrid 106.26 consecutive reductions

GF Jurui Mix A 101.06 New

GF Pharmaceutical Health Mix A 99.47 continued to increase holdings

Harvest and two-year holding period mixed 58.69 reduction

GF Shengxing Hybrid A 54.93 new

Boc China Hybrid (LOF) A 53.65 continued to increase holdings

NORD Cyclical Strategy Mix 51.71 consecutive overweights

Huatai Berry Quality Growth Blend A 50.06 increased holdings

Minsheng plus silver boom industry mix A 41.96 continuous increase in holdings

Dongfang Hong Qixing held a mixed A 38.17 new for three years

NORD Value found 35.19 consecutive increases

Wells Fargo Healthcare Mix A 32.74 Reduction

MINSHENG PLUS SILVER Value Preferred 6-month Holding Period Stock A 32.24 Continuous Increase in Holdings

GF China Medical Index (LOF) A 31.88 consecutive increases

Galaxy Pharmaceutical Hybrid 26.77 consecutive holdings

BOC Strategy Mix 23.59 consecutive overweights

Huatai Berry Quality Preferred A 22.04 continuous reduction

GF Ryan Select Stock A 19.29 New

GF Innovation Medical's two-year holding period hybrid A 18.53 continued to increase holdings

HY Healthcare A 18.50 New

Soochow Smart Medical A 18.45 reduction

Ping An CSI Pharmaceutical & Medical Device Innovation ETF 17.59 was flat

Huaan Medical Innovation Hybrid A 15.85 Reduction

Huatai Berry Advantage Pilot Hybrid A 15.08 increased holdings

Great Wall Consumer Appreciation Blend 14.10 consecutive reductions

BOC Technology Innovation regularly opens the mix of 14.00 for one year

BOC Blue Chip Hybrid 13.91 consecutive overweights

Minsheng plus silver leading preferred stock 12.85 consecutive increases

Huatai Berry incentive hybrid A 10.00 new entry

Caitong Boom Industry Mix 9.47 continuous increase in holdings

GF Xinyi Blend 7.35 New Entry

Caitong Sustainable Mix 5.87 consecutive overweights

Bosera Premium Brand Blend (LOF) 5.00 consecutive reductions

MINSHENG PLUS BANK Steadily Allocates 9-Month Holding Period Hybrid (FOF) 5.00 Consecutive Holdings

E Fangda CSI Medical ETF 4.84 continuous increase in holdings

HSBC Jinxin Medical Pioneer Hybrid A 4.40 continued to increase holdings

Huatai Berry CSI Full Index Healthcare Equipment and Services ETF 4.30 New

Caitong Multi-Strategy Blessing Blend (LOF) 4.07 consecutive overweights

Tianhong CSI Full Index Healthcare Equipment and Services ETF 3.57 continuous increase in holdings

CCB CSI All Index Healthcare Equipment and Services ETF 3.49 continued to increase holdings

Minsheng plus silver intelligent manufacturing 2025 hybrid 3.30 continuous increase in holdings

Minsheng dividend return 3.07 continuous increase in holdings

Wanjia Quantitative Tongshun Multi Strategy Hybrid A 2.98 New Entry

Southern CSI All-Encompassing Healthcare ETF 2.98 New

Huaxia SSE Pharmaceutical and Health ETF 2.19 reduction

BOC Quality Life Blend 2.13 continued to increase holdings

Dentons CSI Healthcare Devices and Services ETF 2.07 continued to increase holdings

Jinxin Transformation Innovation Growth Hybrid 1.48 consecutive reductions

Shenwan Lingxin SSE G60 Strategic Emerging Industry Component ETF 1.37 New

Guorong Rongsheng leader strictly selected mixed A 0.39 to reduce holdings

Caitong industry leader select hybrid A 0.38 continuous increase in holdings

Jiahe Medical Health Mix 0.32 new

IFC Quantitative Multi-Strategy 0.22 continuous increase in holdings

China Merchants CSI 300 High Beta Index 0.15 New Entry

Tianhong CSI Full Index Healthcare Equipment and Services ETF Initiation Linkage A 0.12 Reduction

Huatai Barry SSE Mid cap ETF connection was flat at 0.01

Read on